FUJIFILM Sonosite Inc., developer of point-of-care ultrasound technology, has announced Rich Fabian, the company’s president and COO, was appointed to the board of The Advanced Medical Technology Association (AdvaMed), a Washington D.C.-based trade association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world.
“I am proud to be a member of the AdvaMed board, particularly now. Since the very onset of the coronavirus (COVID-19), AdvaMed members have been on the front lines, providing patients and health care providers with the protective equipment, diagnostic tests, ventilators, and other vital medical devices and supplies needed to defeat this pandemic,” said Rich Fabian, president and COO, FUJIFILM Sonosite Inc. “At Sonosite, we’ve stepped up to provide educational resources on our point-of-care ultrasound systems, which have been critical to the care delivery of COVID-19 patients. Similarly, AdvaMed steps up in times of crisis and has been a steady advocate for our industry, facilitating advances in medical technologies in the form of new diagnostics, new treatments, and new medical devices.”
As leaders in point-of-care ultrasound (POCUS), Fujifilm is dedicated to empowering clinicians, affording them the ability to bring ultrasound to any patient, anywhere, at any time. The company pushes the boundaries of innovation with a progressive product line, educational programs, and advocacy for a broader understanding of the benefit of POCUS.
AdvaMed advocates globally for the highest ethical standards and patient access to safe, effective and innovative medical technologies that save and improve lives. Member companies of AdvaMed produce the medical devices, diagnostic products and health information systems that are transforming global health care through earlier disease detection, less invasive procedures and more effective treatments.
“We’re excited to have Rich join the AdvaMed Board of Directors. He is widely recognized as a strong advocate for the MedTech Industry—especially the promotion of breakthrough technologies and innovative solutions for our most pressing health needs,” says Scott Whitaker, President and CEO of AdvaMed. “We look forward to his contributions as a board member, especially during these challenging times as our industry is working to deliver the devices and diagnostics crucial to our fight against COVID-19.” – MPO